Related Experiment Video
Updated: Jun 1, 2026

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy
Micol Falabella1, Sandra Lopez Calcerrada2, Jana Aref3
1Department of Neuromuscular Diseases, University College London Queen Square Institute of Neurology, London, UK. m.falabella@ucl.ac.uk.
Abstract:
Primary mitochondrial diseases (PMDs) affect approximately 1 in 4300 individuals and cause early-onset neuromuscular and multisystem dysfunction with reduced lifespan. They result from pathogenic variants in mitochondrial or nuclear DNA that impair oxidative phosphorylation. Cytochrome c oxidase (COX; complex IV) deficiency is a well-established cause of PMD, leading to a broad spectrum of phenotypes. COXFA4 (cytochrome c oxidase subunit FA4), formerly NDUFA4, is a nuclear-encoded COX subunit, but its role in disease remains poorly defined. We report the largest genetically confirmed cohort of COXFA4-related PMD to date, comprising 13 individuals from 12 families with biallelic pathogenic COXFA4 variants. All present with Leigh-like encephalopathy and complete loss of COXFA4 protein; however, patient-derived fibroblasts retain residual COX activity, with upregulation of COXFA4L2 (cytochrome c oxidase subunit FA4-like 2), a poorly characterised paralog. Here, we show that COXFA4 is a late-stage COX assembly subunit and identify a paralog-mediated compensatory mechanism with translational potential.
Insights
Primary mitochondrial diseases (PMDs) are linked to COXFA4 gene variants. A compensatory mechanism involving COXFA4L2 may offer therapeutic potential for Leigh-like encephalopathy.
Area of Science:
- Genetics
- Biochemistry
- Neurology
Background:
- Primary mitochondrial diseases (PMDs) are genetic disorders affecting ~1 in 4300 individuals, causing early-onset neuromuscular and multisystem dysfunction.
- Oxidative phosphorylation defects, particularly cytochrome c oxidase (COX; complex IV) deficiency, are common causes of PMDs with diverse clinical presentations.
- The role of COXFA4 (cytochrome c oxidase subunit FA4), a nuclear-encoded COX subunit, in disease pathogenesis is not well understood.
Purpose of the Study:
- To investigate the clinical and genetic spectrum of PMD caused by pathogenic variants in the COXFA4 gene.
- To elucidate the molecular mechanisms underlying COXFA4 deficiency and identify potential compensatory pathways.
- To explore the functional relationship between COXFA4 and its paralog, COXFA4L2.
Main Methods:
- Genetic analysis of 13 individuals from 12 families with suspected PMD.
- Assessment of COXFA4 protein levels and COX activity in patient-derived fibroblasts.
- Analysis of COXFA4L2 expression and its role in COX assembly and activity.
Main Results:
- Identified 13 individuals with biallelic pathogenic COXFA4 variants, presenting with Leigh-like encephalopathy and complete loss of COXFA4 protein.
- Patient-derived fibroblasts showed residual COX activity despite absent COXFA4.
- Upregulation of the poorly characterized paralog COXFA4L2 was observed, suggesting a compensatory mechanism.
Conclusions:
- COXFA4 is a crucial late-stage assembly subunit of cytochrome c oxidase.
- A paralog-mediated compensatory mechanism involving COXFA4L2 can partially restore COX activity in COXFA4-deficient cells.
- This compensatory pathway holds translational potential for therapeutic strategies in COXFA4-related PMD.
More Related Videos
05:27Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools
Published on: July 20, 2022
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry
Published on: November 23, 2011
Related Concept Videos
Hepatic Encephalopathy
Cofactors and Coenzymes
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors and Coenzymes
Cofactors and Coenzymes
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Electron Transport Chain: Complex III and IV